LAM
UTHR icon

Lebenthal Asset Management’s United Therapeutics UTHR Stock Holding History

Lebenthal Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$495K Buy
+3,656
New +$554K 0.06% 259

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lebenthal Asset Management's UTHR Position: Q1 2017 in Review

Lebenthal Asset Management opened a new position in United Therapeutics (UTHR) in Q1 2017: 3,656 shares worth $495K. The stake represents 0.06% of the portfolio and ranks #259 among its holdings.

411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • Lebenthal Asset Management held 3,656 shares of United Therapeutics worth $495K as of Q1 2017.
  • United Therapeutics was a new Lebenthal Asset Management position in Q1 2017.
  • United Therapeutics made up 0.06% of Lebenthal Asset Management's portfolio in Q1 2017, its #259 holding.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.